Vendor review
Yimei reviews
Yimei reviews from 131 independent lab tests (Retatrutide, GHK-Cu and BPC-157): grade A, purity and fill accuracy. Is Yimei legit? See what its vials showed.
Grade A131 independent lab tests0 peptides listedShips from China
What the lab tests show
131 tests on record, newest first. Scores are purity divided by ten.
| Date | Product | Purity | Quantity | Identity | Certificate |
|---|---|---|---|---|---|
| Oct 14, 2026 | Retatrutide | 99.99 % | 28.89 mg of 30 mg (-4 %) | Pass | View |
| Sep 25, 2026 | hCG | 99.9 % | 10000 IU of 10000 IU (0 %) | Pass | View |
| Sep 25, 2026 | NAD+ | 98.7 % | 472 mg of 500 mg (-6 %) | Pass | View |
| Aug 21, 2026 | Epithalon | 99.6 % | 9.7 mg of 10 mg (-3 %) | Pass | View |
| Aug 21, 2026 | BPC-157 | 83.8 % | 12.4 mg of 10 mg (24 %) | Pass | View |
| Aug 21, 2026 | GHK-Cu | 99.7 % | 56.6 mg of 50 mg (13 %) | Pass | View |
| Aug 21, 2026 | TB-500 | 99.6 % | 5.7 mg of 5 mg (14 %) | Pass | View |
| Aug 20, 2026 | TB-500 | 5 mg | View | ||
| Aug 16, 2026 | Retatrutide | 99.8 % | 10.1 mg of 10 mg (1 %) | Pass | View |
| Aug 15, 2026 | GHK-Cu | 50 mg | View | ||
| Jul 10, 2026 | Retatrutide | 99.8 % | 15.4 mg of 15 mg (3 %) | Pass | View |
| Jun 17, 2026 | BPC-157 | 99.9 % | 8.19 mg of 10 mg (-18 %) | Pass | View |
| Jun 16, 2026 | Retatrutide | 99.9 % | 18.5 mg of 20 mg (-8 %) | Pass | View |
| May 20, 2026 | hCG | 99.9 % | 4980 mg of 5000 mg (0 %) | Pass | View |
| May 19, 2026 | Tirzepatide | 99.9 % | 54.6 mg of 60 mg (-9 %) | Pass | View |
| May 6, 2026 | MOTS-c | 99.9 % | 12.2 mg of 10 mg (22 %) | Pass | View |
| Apr 30, 2026 | Retatrutide | 99.8 % | 21.5 mg of 20 mg (8 %) | Pass | View |
| Apr 30, 2026 | CJC-1295 | 99.5 % | 6.5 mg of 5 mg (30 %) | Pass | View |
| Apr 30, 2026 | Ipamorelin | 99.8 % | 4.5 mg of 5 mg (-10 %) | Pass | View |
| Apr 28, 2026 | Retatrutide | 99.9 % | 28.1 mg of 30 mg (-6 %) | Pass | View |
| Apr 28, 2026 | Retatrutide | 99.9 % | 15.2 mg of 15 mg (1 %) | Pass | View |
| Apr 28, 2026 | Retatrutide | 99.9 % | 27.3 mg of 30 mg (-9 %) | Pass | View |
| Apr 28, 2026 | Tirzepatide | 99.9 % | 36.5 mg of 30 mg (22 %) | Pass | View |
| Apr 28, 2026 | CJC-1295 | 99.4 % | 5.06 mg of 5 mg (1 %) | Pass | View |
| Apr 28, 2026 | Ipamorelin | 99.9 % | 10.6 mg of 10 mg (6 %) | Pass | View |
| Apr 28, 2026 | MOTS-c | 98.8 % | 40.7 mg of 40 mg (2 %) | Pass | View |
| Apr 23, 2026 | GHK-Cu | 99.9 % | 92.5 mg of 100 mg (-8 %) | Pass | View |
| Apr 23, 2026 | Retatrutide | 98.4 % | 50.4 mg of 50 mg (1 %) | Pass | View |
| Mar 21, 2026 | BPC-157 | 99.8 % | 23.8 mg of 10 mg (138 %) | Pass | View |
| Mar 19, 2026 | Retatrutide | 99.9 % | 20.1 mg of 20 mg (1 %) | Pass | View |
| Mar 18, 2026 | Retatrutide | 99.9 % | 25 mg of 30 mg (-17 %) | Pass | View |
| Mar 18, 2026 | CJC-1295 | 89.3 % | 4.39 mg of 5 mg (-12 %) | Pass | View |
| Mar 10, 2026 | Retatrutide | 99.9 % | 9.71 mg of 10 mg (-3 %) | Pass | View |
| Mar 10, 2026 | hCG | 99.9 % | 1.03 IU of 10 IU (-90 %) | Pass | View |
| Mar 7, 2026 | Retatrutide | 99.7 % | 15.6 mg of 15 mg (4 %) | Pass | View |
| Mar 7, 2026 | TB-500 | 99.9 % | 4.7 mg of 5 mg (-6 %) | Pass | View |
| Mar 7, 2026 | Tesamorelin | 99.7 % | 5 mg of 5 mg (0 %) | Pass | View |
| Mar 6, 2026 | GHK-Cu | 99.9 % | 83.5 mg of 100 mg (-17 %) | Pass | View |
| Mar 6, 2026 | BPC-157 | 99.9 % | 9.8 mg of 10 mg (-2 %) | Pass | View |
| Mar 6, 2026 | BPC-157 | 99.9 % | 4.47 mg of 5 mg (-11 %) | Pass | View |
| Mar 6, 2026 | Retatrutide | 99.9 % | 5.96 mg of 5 mg (19 %) | Pass | View |
| Mar 6, 2026 | CJC-1295 | 99.9 % | 4.69 mg of 5 mg (-6 %) | Pass | View |
| Mar 6, 2026 | Ipamorelin | 99.9 % | 4.28 mg of 5 mg (-14 %) | Pass | View |
| Mar 4, 2026 | TB-500 | 53.44 % | 13.2 mg of 10 mg (32 %) | Pass | View |
| Mar 4, 2026 | GHK-Cu | 99.7 % | 58 mg of 50 mg (16 %) | Pass | View |
| Mar 4, 2026 | BPC-157 | 99.9 % | 9.14 mg of 10 mg (-9 %) | Pass | View |
| Mar 4, 2026 | BPC-157 | 10 mg | Fail | View | |
| Mar 4, 2026 | Retatrutide | 99.9 % | 10.1 mg of 10 mg (1 %) | Pass | View |
| Mar 4, 2026 | Retatrutide | 99.6 % | 10.8 mg of 10 mg (8 %) | Pass | View |
| Mar 4, 2026 | Retatrutide | 99.9 % | 4.84 mg of 5 mg (-3 %) | Pass | View |
| Mar 4, 2026 | CJC-1295 | 99.72 % | 5.06 mg of 5 mg (1 %) | Pass | View |
| Mar 3, 2026 | Retatrutide | 99.53 % | 48 mg of 50 mg (-4 %) | Pass | View |
| Mar 3, 2026 | Retatrutide | 98.54 % | 8.76 mg of 10 mg (-12 %) | Pass | View |
| Mar 2, 2026 | Retatrutide | 99.86 % | 14.2 mg of 15 mg (-5 %) | Pass | View |
| Mar 2, 2026 | GHK-Cu | 99.9 % | 44.2 mg of 50 mg (-12 %) | Pass | View |
| Mar 2, 2026 | Retatrutide | 99.86 % | 10.2 mg of 10 mg (2 %) | Pass | View |
| Mar 2, 2026 | Tirzepatide | 99.9 % | 13.8 mg of 10 mg (38 %) | Pass | View |
| Mar 2, 2026 | Ipamorelin | 99.9 % | 4.73 mg of 5 mg (-5 %) | Pass | View |
| Mar 2, 2026 | Tesamorelin | 99.9 % | 4.4 mg of 5 mg (-12 %) | Pass | View |
| Mar 1, 2026 | Retatrutide | 99.7 % | 9.4 mg of 10 mg (-6 %) | Pass | View |
What Yimei sells
No current listings on record.
About Yimei
According to Pepaura Yimei is rebranding to Pepturion